Schizophrenia future or investigational therapies
|
Schizophrenia Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Schizophrenia future or investigational therapies On the Web |
|
American Roentgen Ray Society Images of Schizophrenia future or investigational therapies |
|
Schizophrenia future or investigational therapies in the news |
|
Risk calculators and risk factors for Schizophrenia future or investigational therapies |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Future or Investigational Therapies
Service-user led movements have become integral to the recovery process in Europe and America; groups such as the Hearing Voices Network and the Paranoia Network have developed a self-help approach that aims to provide support and assistance outside the traditional medical model adopted by mainstream psychiatry. By avoiding framing personal experience in terms of criteria for mental illness or mental health, they aim to destigmatize the experience and encourage individual responsibility and a positive self-image. Partnerships between hospitals and consumer-run groups are becoming more common, with services working toward remediating social withdrawal, building social skills and reducing rehospitalization.[1]
The Soteria model is an alternative treatment to institutionalization and early use of antipsychotics.[2] It is described as a milieu-therapeutic recovery method, characterized by its founder as "the 24 hour a day application of interpersonal phenomenologic interventions by a nonprofessional staff, usually without neuroleptic drug treatment, in the context of a small, homelike, quiet, supportive, protective, and tolerant social environment."[3] Soteria or Soteria-based houses are currently run in Sweden,[4] Germany,[5][6][7] Switzerland,[8] and Hungary.[9] The Soteria house in Berne, Switzerland is associated with a psychiatrist who teaches at the University of Berne, and has been featured in the Schweizerische Aertzezeitung, the Bulletin of Swiss Physicians.[10]
The biologically based branch of alternative medicine that deals with schizophrenia is known as orthomolecular psychiatry. Some scientists claim that schizophrenia can be treated effectively with nutrients like niacin, vitamin C and B6, omega-3 EFAs (fish oil) along with various minerals and amino acids.[11][12] The body's adverse reactions to gluten and other allergens are implicated in some alternative theories as the cause of some cases. This theory—discussed by one author in three British journals in the 1970s[13]—is unproven. A 2006 literature review suggests that gluten may be a factor for a subset of patients with schizophrenia, but further study is needed to confirm the association between gluten and schizophrenia.[14]
An unconventional approach is the use of omega-3 fatty acids, with one study finding some benefits from their use as a dietary supplement.[15]
References
- ↑ Goering P, Durbin J, Sheldon CT, Ochocka J, Nelson G, Krupa T. Who uses consumer-run self-help organizations? American Journal of Orthopsychiatry, 76 (3), 367-73. PMID 16981815
- ↑ Bola JR, Mosher LR (April 2003). "Treatment of Acute Psychosis Without Neuroleptics: Two-Year Outcomes From the Soteria Project" (PDF). The Journal of Nervous and Mental Disease. Lippincott Williams & Wilkins, Inc. 191: 219–229. PMID 12695732. Retrieved 2007-06-13.
- ↑ Mosher LR (1999). "Soteria and Other Alternatives to Acute Psychiatric Hospitalization: A Personal and Professional Review." Journal of Nervous and Mental Disease, 187, 142–149.
- ↑ Perris, C.M. Cognitive Therapy with Schizophrenic Patients. Guilford, New York, NY, 1989.
- ↑ Allgemeine Psychiatrie I / Soteria
- ↑ Toll - Haus
- ↑ Soteria
- ↑ Soteria Bern
- ↑ Soteria Alapítvány
- ↑ http://www.soteria.ch/pdf/Soteria%20Bern%20SAEZ.pdf Soteria
- ↑ Hoffer and Walker, Orthomolecular Nutrition. Keats Publishing, 1978
- ↑ Abram Hoffer (1999) Orthomolecular treatment for Schizophrenia, McGraw-Hill, ISBN 0879839104
- ↑ Dohan FC (1970). Coeliac disease and schizophrenia. Lancet, 1970 April 25;1(7652):897–8. PMID 4191543
*Dohan FC (1973). Coeliac disease and schizophrenia. British Medical Journal, 3(5870): 51–52. PMID 4740433
* Dohan FC (1979). Celiac-type diets in schizophrenia. Am J Psychiatry, 1979 May;136(5):732–3. PMID 434265 - ↑ Kalaydjian AE, Eaton W, Cascella N, Fasano A (2006). The gluten connection: the association between schizophrenia and celiac disease. Acta Psychiatrica Scandinavica 2006 Feb;113(2):82–90. PMID 16423158
- ↑ Peet M, Stokes C (2005). Omega-3 fatty acids in the treatment of psychiatric disorders. Drugs, 65(8), 1051–9. PMID 15907142